Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Open Forum Infectious Diseases|July 16, 2020
Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic CancerMichael J Boeckh, Ann M Arvin, Kathleen M Mullane, et al.The Journal of Infectious Diseases|August 3, 2013
Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adultsKathleen M Mullane, Drew J Winston, Michael S Wertheim, et al.Journal of Translational Medicine|May 3, 2008
Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanomaBegoña Comin-Anduix, Yohan Lee, Jason Jalil, et al.Cancer|March 26, 2004
Biochemotherapy in patients with metastatic anorectal mucosal melanomaKevin B Kim, Angela M Sanguino, Cynthia Hodges, et al.Melanoma Research|June 7, 2012
A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanomaKevin B Kim, Victor Prieto, Richard W Joseph, et al.Journal of Translational Medicine|September 30, 2010
Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanomaAntoni Ribas, Luis H Camacho, Sun Min Lee, et al.Cancer|April 23, 2014
Dual inhibition of the vascular endothelial growth factor pathway: a phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumorsDavid S Hong, Ignacio Garrido-Laguna, Suhendan Ekmekcioglu, et al.Ebiomedicine|October 30, 2025
Safety and efficacy of intratumourally administered INT230-6 in adult patients with advanced solid tumours: results from an open-label phase 1/2 dose escalation studyJacob S Thomas, Lillian L Siu, Matthew Ingham, et al.The New England Journal of Medicine|June 5, 2012
Safety and activity of anti-PD-L1 antibody in patients with advanced cancerJulie R Brahmer, Scott S Tykodi, Laura Q M Chow, et al.Pageof 4